Goal and Learning Outcomes

The goal of this continuing education program is to outline various aspects of hypercoagulability disorders, with a primary focus on venous thromboembolism (VTE). After studying the information presented here, you will be able to:
  • Identify risk factors and symptoms associated with hypercoagulability disorders, including deep vein thrombosis and pulmonary embolism
  • Describe the tests and tools available to assess the risk of developing a blood clot
  • Review how evidence-based guidelines for the prevention and treatment of VTE can be used by the healthcare team
  • Analyze treatment modalities and identify goals of therapy in the management of VTE and how various members of the healthcare team can contribute to the care process
  • Review key patient education points that the healthcare team should emphasize regarding the symptoms of thrombosis, outcomes of pharmacotherapy, lifestyle interventions, etc.
  • Discuss challenges encountered with patient adherence to anticoagulant therapy

Course Authors

Accreditation Information


In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791



Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, New Mexico Board Of Nursing, South Carolina Board Of Nursing and  West Virginia Board Of Examiners For Registered Professional Nurses


Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.



None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.